These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 17524981)
1. Design, synthesis, and evaluation of in vivo potency and selectivity of epoxysuccinyl-based inhibitors of papain-family cysteine proteases. Sadaghiani AM; Verhelst SH; Gocheva V; Hill K; Majerova E; Stinson S; Joyce JA; Bogyo M Chem Biol; 2007 May; 14(5):499-511. PubMed ID: 17524981 [TBL] [Abstract][Full Text] [Related]
2. Mechanistic studies on the inactivation of papain by epoxysuccinyl inhibitors. Meara JP; Rich DH J Med Chem; 1996 Aug; 39(17):3357-66. PubMed ID: 8765519 [TBL] [Abstract][Full Text] [Related]
3. Design of potent, selective, and orally bioavailable inhibitors of cysteine protease cathepsin k. Tavares FX; Boncek V; Deaton DN; Hassell AM; Long ST; Miller AB; Payne AA; Miller LR; Shewchuk LM; Wells-Knecht K; Willard DH; Wright LL; Zhou HQ J Med Chem; 2004 Jan; 47(3):588-99. PubMed ID: 14736240 [TBL] [Abstract][Full Text] [Related]
4. Novel aza peptide inhibitors and active-site probes of papain-family cysteine proteases. Verhelst SH; Witte MD; Arastu-Kapur S; Fonovic M; Bogyo M Chembiochem; 2006 Jun; 7(6):943-50. PubMed ID: 16607671 [TBL] [Abstract][Full Text] [Related]
5. 3,4-disubstituted azetidinones as selective inhibitors of the cysteine protease cathepsin K. Exploring P3 elements for potency and selectivity. Setti EL; Davis D; Janc JW; Jeffery DA; Cheung H; Yu W Bioorg Med Chem Lett; 2005 Mar; 15(5):1529-34. PubMed ID: 15713422 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of cysteine proteases by peptides containing aziridine-2,3-dicarboxylic acid building blocks. Schirmeister T Biopolymers; 1999; 51(1):87-97. PubMed ID: 10380356 [TBL] [Abstract][Full Text] [Related]
7. Binding modes of a new epoxysuccinyl-peptide inhibitor of cysteine proteases. Where and how do cysteine proteases express their selectivity? Czaplewski C; Grzonka Z; Jaskólski M; Kasprzykowski F; Kozak M; Politowska E; Ciarkowski J Biochim Biophys Acta; 1999 May; 1431(2):290-305. PubMed ID: 10350606 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of chloromethyl sulfoxides as a new class of selective irreversible cysteine protease inhibitors. Brouwer AJ; Bunschoten A; Liskamp RM Bioorg Med Chem; 2007 Nov; 15(22):6985-93. PubMed ID: 17869119 [TBL] [Abstract][Full Text] [Related]
9. Inactivation of cysteine proteases by peptidyl epoxides: characterization of the alkylation sites on the enzyme and the inactivator. Albeck A; Kliper S Biochem J; 2000 Feb; 346 Pt 1(Pt 1):71-6. PubMed ID: 10657241 [TBL] [Abstract][Full Text] [Related]
10. Development of cell-active non-peptidyl inhibitors of cysteine cathepsins. Dana D; Davalos AR; De S; Rathod P; Gamage RK; Huestis J; Afzal N; Zavlanov Y; Paroly SS; Rotenberg SA; Subramaniam G; Mark KJ; Chang EJ; Kumar S Bioorg Med Chem; 2013 Jun; 21(11):2975-87. PubMed ID: 23623677 [TBL] [Abstract][Full Text] [Related]
11. Syntheses and SH-enzyme inhibitory activities of new epoxysuccinic acid piperazine derivatives against mu-calpain and cathepsin B. Inoue J; Yoshida Y; Nakamura M; Cui YS; Nagao Y Drug Des Discov; 1999 Aug; 16(2):165-9. PubMed ID: 10533812 [TBL] [Abstract][Full Text] [Related]
12. Screening for selective small molecule inhibitors of the proteasome using activity-based probes. Bogyo M Methods Enzymol; 2005; 399():609-22. PubMed ID: 16338384 [TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis, and Structure-Activity Relationship Study of Epoxysuccinyl-Peptide Derivatives as Cathepsin B Inhibitors. Zhang X; Yang X; Wang H; Li S; Guo K; Jiang D; Xiao J; Liang D Biol Pharm Bull; 2017 Aug; 40(8):1240-1246. PubMed ID: 28502922 [TBL] [Abstract][Full Text] [Related]
15. Solid-phase synthesis of double-headed epoxysuccinyl activity-based probes for selective targeting of papain family cysteine proteases. Verhelst SH; Bogyo M Chembiochem; 2005 May; 6(5):824-7. PubMed ID: 15776409 [No Abstract] [Full Text] [Related]
16. Azadipeptide nitriles: highly potent and proteolytically stable inhibitors of papain-like cysteine proteases. Löser R; Frizler M; Schilling K; Gütschow M Angew Chem Int Ed Engl; 2008; 47(23):4331-4. PubMed ID: 18404765 [No Abstract] [Full Text] [Related]
17. Peptidyl epoxides extended in the P' direction as cysteine protease inhibitors: effect on affinity and mechanism of inhibition. Perlman N; Hazan M; Shokhen M; Albeck A Bioorg Med Chem; 2008 Oct; 16(19):9032-9. PubMed ID: 18789705 [TBL] [Abstract][Full Text] [Related]
18. Theoretical studies of binding modes of two covalent inhibitors of cysteine proteases. Drabik P; Politowska E; Czaplewski C; Kasprzykowski F; Lankiewicz L; Ciarkowski J Acta Biochim Pol; 2000; 47(4):1061-6. PubMed ID: 11996096 [TBL] [Abstract][Full Text] [Related]
19. Aza-peptide epoxides: a new class of inhibitors selective for clan CD cysteine proteases. Asgian JL; James KE; Li ZZ; Carter W; Barrett AJ; Mikolajczyk J; Salvesen GS; Powers JC J Med Chem; 2002 Nov; 45(23):4958-60. PubMed ID: 12408706 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and evaluation of aza-peptide epoxides as selective and potent inhibitors of caspases-1, -3, -6, and -8. James KE; Asgian JL; Li ZZ; Ekici OD; Rubin JR; Mikolajczyk J; Salvesen GS; Powers JC J Med Chem; 2004 Mar; 47(6):1553-74. PubMed ID: 14998341 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]